Literature DB >> 23992939

Triclosan-coated sutures reduce wound infections after spinal surgery: a retrospective, nonrandomized, clinical study.

Masaki Ueno1, Wataru Saito2, Megumu Yamagata3, Takayuki Imura2, Gen Inoue2, Toshiyuki Nakazawa2, Naonobu Takahira4, Kentaro Uchida2, Nobuko Fukahori3, Kiyomi Shimomura3, Masashi Takaso2.   

Abstract

BACKGROUND CONTEXT: Surgical site infection (SSI) is a serious postoperative complication. The incidence of SSIs is lower in clean orthopedic surgery than in other fields, but it is higher after spinal surgery, reaching 4.15% in high-risk patients. Several studies reported that triclosan-coated polyglactin 910 sutures (Vicryl Plus; Ethicon, Inc., Somerville, NJ, USA) significantly reduced the infection rate in the general surgical, neurosurgical, and thoracic surgical fields. However, there have been no studies on the effects of such coated sutures on the incidence of SSIs in orthopedics.
PURPOSE: To compare the incidence of wound infections after spinal surgery using triclosan-coated suture materials with that of noncoated ones. STUDY DESIGN/
SETTING: A retrospective, nonrandomized, and clinical study. PATIENT SAMPLE: From May 2010 to April 2012, 405 patients underwent a spinal surgical procedure in the Department of Orthopedic Surgery of two university hospitals. OUTCOME MEASURES: The primary outcome was the number of wound infections and dehiscences.
METHODS: Two hundred five patients had a conventional wound closure with polyglactin 910 suture (Vicryl) between May 2010 and April 2011 (Time Period 1 [TP1]), and 200 patients underwent wound closure with triclosan-coated polyglactin 910 suture (Vicryl Plus) between May 2011 and April 2012 (TP2). Statistical comparisons of wound infections, dehiscence, and risk factors for poor wound healing or infection were performed. None of the authors has any conflict of interest associated with this study.
RESULTS: There were two cases of wound dehiscence in TP1 and one in TP2 (p=.509). Using noncoated sutures in TP1, eight patients (3.90%) had wound infections, whereas one patient (0.50%) had wound infections in TP2 (using triclosan-coated sutures); the difference was significant (p=.020).
CONCLUSIONS: The use of triclosan-coated polyglactin 910 sutures instead of polyglactin 910 sutures may reduce the number of wound infections after spinal surgery.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Antimicrobial suture; Spinal surgery; Surgical site infection; Triclosan; Wound closure

Mesh:

Substances:

Year:  2013        PMID: 23992939     DOI: 10.1016/j.spinee.2013.06.046

Source DB:  PubMed          Journal:  Spine J        ISSN: 1529-9430            Impact factor:   4.166


  5 in total

1.  Comparison of Antimicrobial Activity Between Bacitracin-Soaked Sutures and Triclosan Coated Suture.

Authors:  Jeremy M Adkins; Roy Al Ahmar; Hongwei D Yu; Shane T Musick; Anthony M Alberico
Journal:  J Surg Res       Date:  2021-10-23       Impact factor: 2.192

Review 2.  [Infections after reconstructive spinal interventions : How do I deal with them?]

Authors:  Burkhard Lehner; Michael Akbar; Nicholas A Beckmann
Journal:  Orthopade       Date:  2018-04       Impact factor: 1.087

Review 3.  Burden of Surgical Site Infections Associated with Select Spine Operations and Involvement of Staphylococcus aureus.

Authors:  Harshila Patel; Hanane Khoury; Douglas Girgenti; Sharon Welner; Holly Yu
Journal:  Surg Infect (Larchmt)       Date:  2016-11-30       Impact factor: 2.150

Review 4.  Antimicrobial-coated sutures to decrease surgical site infections: a systematic review and meta-analysis.

Authors:  X Wu; N Z Kubilay; J Ren; B Allegranzi; P Bischoff; B Zayed; D Pittet; J Li
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-09-02       Impact factor: 3.267

5.  Is There an Optimal Wound Closure Technique for Major Posterior Spine Surgery? A Systematic Review.

Authors:  Emre Yilmaz; Ronen Blecher; Marc Moisi; Chandra Ankush; Thomas M O'Lynnger; Amir Abdul-Jabbar; Joseph R Dettori; Rod J Oskouian
Journal:  Global Spine J       Date:  2018-05-23
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.